Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

. 2008 Jun 25;46(8):2605–2612. doi: 10.1128/JCM.00640-08

TABLE 4.

Geographic distribution of E. coli strains belonging to clonal groups O25:H4 ST-131 and O15:K52:H1

Country (total no. of E. coli strains collected during the ARESC study) No. of E. coli strains with ciprofloxacin MICs of ≥2 μg/ml (%) No. of O25: H4 ST-131 and O15:K52:H1 E. coli strains/no. of E. coli strains with ciprofloxacin MICs of ≥2 μg/ml (%a)
Austria (62) 1 (1.6%) 1/1
France (409) 6 (1.4%) 4/6
Germany (243) 9 (3.7%) 4/9
Hungary (52) 2 (3.8%) 1/2
Italy (239) 29 (12.2%) 10/29 (34.4%)
Poland (90) 6 (6.7%) 0/6
Russia (302) 41 (13.6%) 9/41 (21.9%)
Spain (515) 55 (10.7%) 22/55 (40.0%)
a

Percentages were reported only for those countries providing more than 10 strains.

HHS Vulnerability Disclosure